Global Biofungicides Market is valued approximately USD 1.4 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 16.1 % over the forecast period 2020-2027. Biofungicides are fungicides which contain a microorganism as the active ingredient and is used to control the spread of fungal pathogens in crops. It is also used as a pest-control in the cultivation of fruits & vegetables, cereals, grains, oilseeds & pulses. The global Biofungicides market is facing challenges due to the coronavirus pandemic which is disrupting some activities in agriculture and supply chains. However, Government of various countries are taking several steps to respond the crisis. For instance: The Reserve Bank of India (RBI) has also announced the "burden of debt servicing" due to COVID-19 pandemic. Agricultural term and crop loans have been granted a moratorium of three months (till May 31) by banking institutions with 3% concession on the interest rate of crop loans up to INR 300,000 (USD 39367.50) for borrowers. Moreover, the regulatory pressures and harmful effects associated with the use of synthetic plant protectants, growing emphasis on integrated pest management solutions and rising preference for organic products to encourage the adoption of biological products are the factors responsible for the growth of the market over the forecast period. For Instance: as per Statista, the global sale of organic food was USD 18 billion in 2000 and has risen by USD 95 billion in 2018. However, technological limitations for the use of biological products and need for frequent reapplications of biofungicides as compared to its chemical counterparts is the major factor restraining the growth of global Biofungicides market during the forecast period.
The regional analysis of global Biofungicides Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing use of integrated pest management solutions has lead the growth of the market. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.
Major market player included in this report are:
BASF SE
Bayer AG
Syngenta AG
Nufarm
FMC Corporation
Novozymes
Marrone Bio Innovations
Koppert Biological Systems
Isagro S.P.A
Bioworks
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Microbial species
Botanical
By Form:
Wettable powder
Aqueous solution
Granules
By Species:
Bacillus
Trichoderma
Pseudomonas
Streptomyces
Other species
By Application:
Foliar spray
Soil treatment
Seed treatment
Other modes of application
By Crop-type:
Fruits & vegetables
Cereals & grains
Oilseeds & pulses
Other crops
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2017, 2018
Base year - 2019
Forecast period - 2020 to 2027
Target Audience of the Global Biofungicides Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors